Table 3.
Variables | Control (n = 20) | OSA (n = 74) | ||
---|---|---|---|---|
Mild OSA (n = 15) | Moderate OSA (n = 24) | Severe OSA (n = 35) | ||
HA (ng/ml) | 23.62 ± 5.93 | 33.12 ± 10.6* | 34.53 ± 13.2* | 35.44 ± 10.7** |
PIIINP (ng/ml) | 7.384 ± 1.69 | 7.12 ± 2.28 | 7.368 ± 2.24 | 8.32 ± 3.1 |
CIV (ng/ml) | 41.78 ± 8.72 | 37.41 ± 4.57 | 39.55 ± 3.46 | 45.52 ± 2.45* |
LN (ng/ml) | 27.29 ± 6.39 | 27.37 ± 7.69 | 29.12 ± 7.92 | 30.48 ± 7.4 |
CHI3L1 (ng/ml) | 34.45 (26.7, 41.3) | 35.42 (29.42, 41.2) | 37.88 (29.9, 51.2) | 40.35 (31.9, 54.9)* |
HA, hyaluronan; PIIINP, procollagen type III N-terminal peptide; CIV, type IV collagen; LN, laminin; CHI3L1, Chitinase-3-like protein 1.
p < 0.05, compared with the control group.
p < 0.001, compared with the control group.